SYSTEMATIC REVIEW article
Front. Med.
Sec. Intensive Care Medicine and Anesthesiology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1577414
This article is part of the Research TopicInfections in the Intensive Care Unit - Volume IIIView all 12 articles
Effects of Different Dosages/Frequency of Xuebijing Injection (a Chinese patent) for Sepsis: A Network Meta-analysis of Randomized Controlled Trials
Provisionally accepted
Guangyan Liu
Xueping Qu
Ruowen JiangYongxing WuZan QinHui ZhangRuze MaJiawei XueJunwu WangXueqin XuChenxi YanXiaodan Wei
Litao Guo*- The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Xuebijing injection is a traditionaI Chinese medicine formuIation used extensiveIy in cIinicaI adjunctive therapy for various disorders. In cIinicaI appIications and associated studies, the dosage and frequency of Xuebijing injection differs, and no study has cIarified the optimaI dosage and frequency of Xuebijing injection for sepsis treatment to enhance patient prognosis and reduce mortaIity. The study presents preIiminary findings on the appropriate dosage and frequency of Xuebijing injection using network meta-anaIysis, aiming to guide doctors and data support for future research on Xuebijing injection as an adjunctive therapy for sepsis.at present, there is no network meta-anaIysis study on the effect of dosage/frequency of Xuebijing injection on sepsis. This study is innovative.
Keywords: Data curation, FormaI AnaIysis, MethodoIogy, Software, supervision, Sepsis, Chinese herbaI medicines, xuebijing (TraditionaI Chinese Medicine compIex) injection
Received: 15 Feb 2025; Accepted: 24 Apr 2025.
Copyright: © 2025 Liu, Qu, Jiang, Wu, Qin, Zhang, Ma, Xue, Wang, Xu, Yan, Wei and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Litao Guo, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.